On October 1–2, 2025, the Securing Access through End-to-End Design Workshop took place at the Global Health Campus in Geneva. The event was organized by Unitaid, Clinton Health Access Initiative (CHAI), the Center for Global Health Policy & Politics at Georgetown University, and Treatment Action Group (TAG).
On October 2–3, 2025, the International Scientific and Practical Conference “Central Asia Free of Tuberculosis: From National Successes to Regional Leadership” is taking place in Almaty, Kazakhstan, with the participation of the ITPC EECA team.
Unitaid, CHAI, Wits RHI, and pharmaceutical company Dr. Reddy’s have signed an agreement aimed at ensuring access to injectable lenacapavir for HIV pre-exposure prophylaxis (PrEP) in 120 low- and middle-income countries (LMICs) starting in 2027. The annual cost of the drug will be just $40, with the initial oral lead-in regimen priced at no more than $17.
The UN Secretary-General has presented a report under UN80 — Workstream 3, which outlines reforms to the United Nations system. Among them is a proposal to “complete the work of UNAIDS by the end of 2026,” followed by the “integration of its capacity and expertise into the relevant UN development system structures in 2027.”
In Belarus, elections have been launched to select members of the Country Coordinating Mechanism (CCM) for collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria for a new three-year term. The newly elected body will serve from December 2025 to November 2028.
The non-profit Global Drug Facility (GDF), a division of the Stop TB Partnership, has announced a price reduction for the life-saving drug used to treat drug-resistant tuberculosis (DR-TB) — bedaquiline. A full treatment course produced by Lupin will now be available at USD 63, representing a 30% decrease, while the cost of the full BPaL(M) regimen will fall below USD
As part of its annual activities, the Eurasian Community for Access to Treatment (ECAT) will organize several online meetings with pharmaceutical companies to discuss issues related to the registration, pricing, and availability of essential medicines in Eastern Europe and Central Asia (EECA).
TB Europe Coalition invites everyone to join the educational webinar “Strengthening Community Knowledge and Engagement in the Development of National Strategic Plans (NSPs)”, which will take place on 17 September 2025, from 11:00 to 12:30 CET. You can register via this link.
The U.S. Department of State, Gilead Sciences, and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the launch of a large-scale initiative to expand access to lenacapavir — the first injectable HIV prevention medication administered just twice a year.
The Civil Society Engagement Mechanism for UHC2030 (CSEM) is now accepting nominations for nine open positions on its Advisory Group.
